Abstract
A workshop on the ‘Research potential of a unique xenograft model of human proliferative breast disease’ was held at the Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, in November of 1998. The accumulated information and current experimental findings on the MCF10AT model of preneoplastic, proliferative breast disease were reviewed. Discussions focused on the relevance of the model to clinical breast cancer and on the most profitable lines of further research to strengthen its utility.
Similar content being viewed by others
References
Page DL, Dupont WD: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326–1335, 1990
Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR: MCF10AT: A model for the evolution of cancer from proliferative breast disease. Am J Path 148: 313–319, 1996
Shekhar PVM, Nangia-Makkar P, Wolman SR, Tait L, Heppner GH, Visscher DW: Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Path 152: 1129–1132, 1998
Heppner GH, Wolman SR: MCF-10AT: A model for human breast cancer development. The Breast J 5: 1–8, 1999
Shekhar PVM, Welte R, Christman JK, Wang H, Werdell J: Altered p53 conformation: a novel mechanism of wild-type P53 functional inactivation in a model for early human breast cancer. Int J Oncol 11: 1087–1094, 1997
Tsai YC, Lu Y, Nichols PW, Zlotnikov C, Jones PA, Smith HS: Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res 56: 402–404, 1996
Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057–2059, 1996
Rosenberg CL, Larson PS, Romo JD, De Las Morenas A, Faller DV: Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Human Path 28: 214–219, 1997
Pauley RJ, Soule HD, Tait L, Miller FR, Wolman SR, Dawson PJ, Heppner GH: The MCF10 family of spontaneously immortalized human breast epithelial cell lines and models of neoplastic progression. Eur J Cancer Prevention 2: 67–76, 1993
Roman CA, Cherry SR, Baltimore D: Complementation of V (D) J recombination deficiency in RAG-1 (-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1. Immunity 7: 13–24, 1997
Visonneau S, Cesano A, Torosian MH, Miller EJ, Santoli D: Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. Am J Path 152: 1299–1311, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heppner, G.H., Wolman, S.R., Rosen, J. et al. Research potential of a unique xenograft model of human proliferative breast disease. Breast Cancer Res Treat 58, 183–186 (1999). https://doi.org/10.1023/A:1006344019706
Issue Date:
DOI: https://doi.org/10.1023/A:1006344019706